Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
SU use and the concept of Modern vs. older SUs is a controversial topic, but very relevant to most of us.
We at SAFES (South Asian Federation of Endocrine Societies) feel this requires lot of thinking before we come to any conclusions.
Most of the research and comments from experts do not take into account the differences between SUs and their supporting data. The results are generally packed in bags / clustered together and conclusions are made from them.
We published an in-depth analysis/recommendation and request readers to review this, as we kept the perspective of these different SUs and their mechanism of action in view.
• Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement. Sanjay Kalra, AH Aamir, Abbas Raza, AK Das, AK Azad Khan, Dina Shrestha, Md Faisal Qureshi, Md Fariduddin , Md Faruque Pathan, Fatema Jawad, Jyoti Bhattarai, Nikhil Tandon, Noel Somasundaram, Prasad Katulanda, Rakesh Sahay, Sanjib Dhungel, Sarita Bajaj, Subhankar Chowdhury, Sujoy Ghosh, SV Madhu, Tofail Ahmed, Uditha Bulughapitiya. Indian Journal of Endocrinology and Metabolism (Indian J Endocr Metab)
2015 | September-October | Volume 19 | Issue 5 http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=...
• Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force. Sanjay Kalra, Silver Bahendeka, Rakesh Sahay, Sujoy Ghosh, Fariduddin Md, Abbas Orabi, Kaushik Ramaiya, Sameer Al Shammari, Dina Shrestha, Khalid Shaikh, Sachitha Abhayaratna, Pradeep K Shrestha, Aravinthan Mahalingam, Mazen Askheta, Aly Ahmed A. Rahim, Fatimah Eliana, Hari K Shrestha, Sandeep Chaudhary, Nancy Ngugi, Jean Claude Mbanya, Than Than Aye, Tint Swe Latt, Zhanay A Akanov, Abbas Raza Syed, Nikhil Tandon, AG Unnikrishnan, SV Madhu, Ali Jawa, Subhankar Chowdhury, Sarita Bajaj, Ashok Kumar Das. January-February 2018, Volume 22 | Issue 1
Page Nos. 1-177 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838894/
Thanks
Competing interests:
No competing interests
13 November 2018
Syed Abbas Raza
Consultant Endocrinologist
Shaukat Khanum Cancer Hospital and Research Center.
Shaukat Khanum Cancer Hospital and Research Center.
Rapid Response:
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
SU use and the concept of Modern vs. older SUs is a controversial topic, but very relevant to most of us.
We at SAFES (South Asian Federation of Endocrine Societies) feel this requires lot of thinking before we come to any conclusions.
Most of the research and comments from experts do not take into account the differences between SUs and their supporting data. The results are generally packed in bags / clustered together and conclusions are made from them.
We published an in-depth analysis/recommendation and request readers to review this, as we kept the perspective of these different SUs and their mechanism of action in view.
• Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement. Sanjay Kalra, AH Aamir, Abbas Raza, AK Das, AK Azad Khan, Dina Shrestha, Md Faisal Qureshi, Md Fariduddin , Md Faruque Pathan, Fatema Jawad, Jyoti Bhattarai, Nikhil Tandon, Noel Somasundaram, Prasad Katulanda, Rakesh Sahay, Sanjib Dhungel, Sarita Bajaj, Subhankar Chowdhury, Sujoy Ghosh, SV Madhu, Tofail Ahmed, Uditha Bulughapitiya. Indian Journal of Endocrinology and Metabolism (Indian J Endocr Metab)
2015 | September-October | Volume 19 | Issue 5
http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=...
• Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force. Sanjay Kalra, Silver Bahendeka, Rakesh Sahay, Sujoy Ghosh, Fariduddin Md, Abbas Orabi, Kaushik Ramaiya, Sameer Al Shammari, Dina Shrestha, Khalid Shaikh, Sachitha Abhayaratna, Pradeep K Shrestha, Aravinthan Mahalingam, Mazen Askheta, Aly Ahmed A. Rahim, Fatimah Eliana, Hari K Shrestha, Sandeep Chaudhary, Nancy Ngugi, Jean Claude Mbanya, Than Than Aye, Tint Swe Latt, Zhanay A Akanov, Abbas Raza Syed, Nikhil Tandon, AG Unnikrishnan, SV Madhu, Ali Jawa, Subhankar Chowdhury, Sarita Bajaj, Ashok Kumar Das. January-February 2018, Volume 22 | Issue 1
Page Nos. 1-177
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838894/
Thanks
Competing interests: No competing interests